Falkoner Høreklinik ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  13.4% 12.8% 18.1% 13.4% 18.8%  
Credit score (0-100)  18 18 7 16 6  
Credit rating  BB BB B BB B  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  1 0 0 0 0  
Gross profit  -9.9 55.1 -40.0 -21.6 32.0  
EBITDA  -9.9 55.1 -40.0 -21.6 32.0  
EBIT  -9.9 55.1 -40.0 -21.6 32.0  
Pre-tax profit (PTP)  -9.9 55.1 -40.6 -21.6 32.1  
Net earnings  -9.9 43.9 -40.6 -21.6 32.1  
Pre-tax profit without non-rec. items  -9.9 55.1 -40.6 -21.6 32.1  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  30.1 74.0 33.4 11.8 43.9  
Interest-bearing liabilities  0.0 0.0 3.8 3.8 0.0  
Balance sheet total (assets)  36.3 108 52.1 30.6 78.5  

Net Debt  -36.3 -99.6 -45.2 -21.7 -78.5  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  1 0 0 0 0  
Net sales growth  0.0% -100.0% 0.0% 0.0% 0.0%  
Gross profit  -9.9 55.1 -40.0 -21.6 32.0  
Gross profit growth  0.0% 0.0% 0.0% 46.0% 0.0%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  36 108 52 31 78  
Balance sheet change%  0.0% 198.4% -51.9% -41.4% 156.9%  
Added value  -9.9 55.1 -40.0 -21.6 32.0  
Added value %  -734.2% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 -1.0 0.0 0.0 0.0  
EBIT trend  -1.0 1.0 -1.0 -2.0 1.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  -734.2% 0.0% 0.0% 0.0% 0.0%  
EBIT %  -734.2% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  100.0% 100.0% 100.0% 100.0% 100.0%  
Net Earnings %  -734.2% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  -734.2% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  -734.2% 0.0% 0.0% 0.0% 0.0%  
ROA %  -27.4% 76.2% -49.8% -52.2% 58.7%  
ROI %  -33.1% 106.0% -72.0% -81.9% 107.7%  
ROE %  -33.1% 84.4% -75.6% -95.5% 115.2%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  82.8% 68.2% 64.0% 38.6% 55.9%  
Relative indebtedness %  461.6% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  -2,220.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  365.2% -180.8% 113.1% 100.3% -245.1%  
Gearing %  0.0% 0.0% 11.2% 31.8% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 30.5% 0.0% -3.3%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  5.8 3.1 2.8 1.6 2.3  
Current Ratio  5.8 3.1 2.8 1.6 2.3  
Cash and cash equivalent  36.3 99.6 49.0 25.4 78.5  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  202.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  2,681.6% 0.0% 0.0% 0.0% 0.0%  
Net working capital  30.1 74.0 33.4 11.8 43.9  
Net working capital %  2,220.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0